Beilstein J. Org. Chem.2013,9, 81–88, doi:10.3762/bjoc.9.11
class IV. Despite their name, several HDACs are able to deacetylate a number of nonhistone protein substrates [10][11]. Sirtuins are structurally and mechanistically distinct enzymes.
To date, only two compounds that inhibit HDACs have been FDA approved: suberoylanilide hydroxamicacid (SAHA, 1, trade
PDF
Graphical Abstract
Figure 1:
FDA approved HDAC inhibitors for the treatment of CTCL.
Beilstein J. Org. Chem.2012,8, 1393–1399, doi:10.3762/bjoc.8.161
complicated by competing deacylation, hydroxamicacid formation, etc. We are only aware of two reports [8][9] of the Beckmann rearrangement of β-keto ester oximes. A particular problem was the formation of isoxazolone byproducts, which apparently limited the synthesis to α,α-disubstituted derivatives
PDF
Graphical Abstract
Scheme 1:
The transformation of the phenacyltrioxaadamantane 1 to the N-benzoyltrioxaadamantylmethylamine 5 v...